Canada markets closed

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1300-0.0200 (-13.33%)
At close: 03:44PM EDT
Full screen
Loading interactive chart...
  • Simply Wall St.

    Kane Biotech First Quarter 2024 Earnings: CA$0.01 loss per share (vs CA$0.01 loss in 1Q 2023)

    Kane Biotech ( CVE:KNE ) First Quarter 2024 Results Key Financial Results Net loss: CA$1.49m (loss widened by 24% from...

  • GlobeNewswire

    Kane Biotech Announces First Quarter 2024 Financial Results

    WINNIPEG, Manitoba, May 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces its first quarter 2024 financial results. The Company previously announced on April 11, 2024 that it had reached an agreement in principle for the sale of its entire interest in STEM Animal Health Inc. (“STEM”) to a third party multi-national pharmaceutical company on a cash-free debt-free basis for $8,000,000 USD (the “Transaction”), subject to adjus

  • GlobeNewswire

    Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024

    WINNIPEG, Manitoba, May 16, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will release its first quarter 2024 financial results after market close on Thursday, May 23, 2024. Kane Biotech management will be providing a corporate update at its Special and Annual General Meeting to be hel